This study aims to determine the prevalence of asymmetric hearing loss (AHL) and late onset hearing loss (LOHL) in pediatric cancer patients treated with cisplatin and the risk factors for both AHL and LOHL. This study will also examine the relationship between AHL and LOHL.
Program in Audiology and Communication Sciences, Washington University School of Medicine
Hearing Loss; Cisplatin; Cancer Survivors; Neoplasms; Child
Hayashi, Robert; Hayashi, Sue
Swindall, Margaret Elizabeth, "Late onset and asymmetric sensorineural hearing loss in pediatric cancer survivors following treatment with cisplatin containing chemotherapy regimes" (2016). Independent Studies and Capstones. Paper 725. Program in Audiology and Communication Sciences, Washington University School of Medicine.
Available for download on Tuesday, September 29, 2020